Related Experiment Video
Updated: Aug 7, 2026
02:09
Application of Laparoscopic Partial Splenectomy with Total Blood Flow Occlusion in Benign Splenic Lesions
Published on: December 20, 2024
Outcome of laparoscopic splenectomy based on hematologic indication
1Department of General Surgery, Cleveland Clinic Foundation, Minimally Invasive Surgery Center, 9500 Euclid Avenue, Desk A-80, Cleveland, OH 44195, USA.
Surgical Endoscopy
|April 23, 2002
Summary
Laparoscopic splenectomy is safe and effective for various blood disorders, showing excellent outcomes for Idiopathic Thrombocytopenic Purpura (ITP) and comparable results for hematologic malignancies to benign conditions.
Area of Science:
- Minimally Invasive Surgery
- Gastroenterology
- Hematology
Background:
- Laparoscopic splenectomy is the preferred method for elective splenectomies.
- Limited data exists on outcomes based on hematologic indications.
Purpose of the Study:
- To evaluate the clinical experience, morbidity, and outcomes of laparoscopic splenectomy based on hematologic disease.
- To compare outcomes across different hematologic indications.
Main Methods:
- Retrospective review of 147 laparoscopic splenectomies for nontraumatic splenic pathology (August 1995 - January 2001).
- Evaluation of patient demographics, indications, morbidity, mortality, and clinical outcomes.
- Comparison of hematologic diagnostic groups using Fisher's exact and Wilcoxon rank-sum tests.
Main Results:
- 147 procedures performed; 5% conversion rate to open surgery.
- Idiopathic Thrombocytopenic Purpura (ITP) patients showed shorter operation times, less blood loss, and shorter hospital stays compared to other diagnoses.
- Patients with hematologic malignancies had larger spleens and more blood loss, but similar morbidity and hospital stay lengths compared to benign disease groups.
- High remission rates observed: 85% for ITP, 89% for TTP, 89% for AIHA.
Conclusions:
- Laparoscopic splenectomy is safe and effective for benign and malignant hematologic conditions.
- ITP patients experienced superior outcomes (shorter operations, less blood loss, faster discharge, excellent remission).
- Outcomes for hematologic malignancies were comparable to benign indications, despite challenges like larger spleens.
